Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SZSE: 301096)
Health Care · Life Sciences Tools & Services · CN
CN¥49.30
+2.22% today · -15.0% 1Y
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SZSE: 301096) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $797.08M.
Over the last twelve months the share price has lost 15.0%, trading between 35.20 and 77.17.
Tweenvest scores Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. across four factors: quality 58/100, value 69/100, growth 80/100. Its strongest factor is growth.
301096 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $797.08M
- Revenue (TTM)
- $95.70M
- P/E
- —
- EPS
- -0.67
- Dividend yield
- —
- Beta (5Y)
- 0.49
- 52-week high
- CN¥77.17
- 52-week low
- CN¥35.20
- Avg volume (3M)
- —
- Shares outstanding
- 108.45M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Maccura Biotechnology Co.LtdSZSE: 300463 | $859.07M | CN¥9.53 | +2.47% |
| Pacific Biosciences of California, Inc.NasdaqGS: PACB | $845.46M | $2.44 | -10.48% |
| Boji Medical Technology Co.,Ltd.SZSE: 300404 | $841.23M | CN¥14.73 | +2.01% |
| Shanghai Obio Technology (Group) Corp., Ltd.SHSE: 688238 | $831.61M | CN¥8.85 | +3.87% |
| Ginkgo Bioworks Holdings, Inc.NYSE: DNA | $772.39M | $11.38 | -0.78% |
| Shanghai Model Organisms Center, Inc.SHSE: 688265 | $748.50M | CN¥64.98 | +24.65% |
| Curiox Biosystems Co., LtdKOSDAQ: A445680 | $743.44M | ₩58,200.00 | +17.34% |
| Gubra A/SCPSE: GUBRA | $739.29M | Dkr275.20 | -7.90% |
Figures last refreshed Oct 4, 2026.